Clinical trial
Prodromal Alpha-Synuclein Screening in Parkinson's Disease Study
NCT04724941 is registered in ClinicalTrials.gov with University Hospital Schleswig-Holstein as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prodromal Alpha-Synuclein Screening in Parkinson's Disease Study
- Lead sponsor
- University Hospital Schleswig-Holstein
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 1, 2021
- Completion date
- December 31, 2027
- Enrollment
- 2,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.